Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Butyrate and Taurine for Chronic Postoperative Pain in Adults after Cardiac Surgery

Official title: Butyrate and Taurine for Chronic Postsurgical Pain in Adult Cardiac Surgical Patients: Bayesian Optimized Double-blinded Randomized Controlled Trial

Run by Chinese University of Hong Kong · NCT07144033 · Data updated 2026-11-12

This study tests whether taking taurine and butyrate daily can reduce long-lasting pain after cardiac surgery in adults.

More Pain, Chronic trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment216 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedJune 20, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedOctober 22, 2026
Trial IDNCT07144033 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older undergoing elective CABG, valve repair/replacement, combined CABG/valve, or major aortic procedure via sternotomy, without prior chronic pain or chronic opioid/sedative use and with adequate kidney function.

Probably not a fit

Patients with emergency or redo surgeries, preexisting chronic pain or opioid/sedative use, or severe kidney impairment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, phase II, randomized, double-blinded, placebo-controlled trial using a Bayesian design. Adults undergoing elective cardiac procedures via sternotomy are assigned to taurine plus butyrate or placebo to see if the combination lowers chronic postsurgical pain and improves recovery, while assessing safety and perioperative pain control. The trial will enroll up to 216 participants and follow them through the postoperative period to evaluate pain outcomes and adverse events. The investigation is sponsored by The Chinese University of Hong Kong with Prince of Wales Hospital as the site.

Why it matters

Potential benefit: If successful, the combination could provide a safer method to reduce chronic pain after cardiac surgery and lessen reliance on opioids.

How similar studies have gone: Previous work supports anti-inflammatory and analgesic potential of butyrate and taurine; this specific combinational approach in cardiac surgery is innovative but builds on related evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18 or older
* elective surgery
* coronary artery bypass graft (CABG), valve repair/replacement, combined CABG/valve procedure, or major aortic procedure via sternotomy

Exclusion Criteria:

* emergency surgery
* redo surgery
* history of chronic pain or on chronic opioids/sedatives
* already taking taurine or butyrate prior to enrolment
* renal failure with estimated glomerular filtration rate \<30mL/min (calculated by Cockcroft-Gault formula)
* re-operation within 24 hours after surgery
* intraoperative use of remifentanil
* inability to provide informed consent.

Where it's running

  • Prince of Wales Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Henry Wong, MBChB — Department of Anaesthesia and Intensive Care, The Chinese University of Hong Hong
  • Study coordinator: Henry Wong, MBChB
  • Email: henrymkwong@cuhk.edu.hk
  • Phone: 35052734

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.